Nicotine psychopharmacology research contributions to United States and global tobacco regulation: A look back and a look forward

Psychopharmacology

Volumn 184, Issue 3-4, 2006, Pages 286-291

  Henningfield, Jack E ^a,b   Zeller, Mitch ^a  

^a PINNEY ASSOCIATES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abuse liability; Addiction; Dependence potential; History; Nicotine; Policy; Psychopharmacology; Public Health; Regulatory; Tobacco

Indexed keywords

NICOTINE;

CIGARETTE SMOKING; CLINICAL RESEARCH; CONFERENCE PAPER; DRUG DEPENDENCE; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SMOKELESS TOBACCO; SMOKING; SURGEON; TOBACCO DEPENDENCE; TOBACCO INDUSTRY; WORLD HEALTH ORGANIZATION;

ANIMALS; BRAIN; FORECASTING; HEALTH POLICY; HUMANS; NICOTINE; RESEARCH; SMOKING; SMOKING CESSATION; TOBACCO INDUSTRY; TOBACCO USE DISORDER; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 32844473213     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0308-4     Document Type: Conference Paper

References (79)

1. American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders, Third edn. American Psychiatric Association, Washington, DC
2. Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman AL (1983) Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 309:139-142
3. Collins AC, Romm E, Wehner JM (1988) Nicotine tolerance: an analysis of the time course of its development and loss in the rat. Psychopharmacology 96:7-14
4. Corrigall WA (1999) Nicotine self-administration in animals as a dependence model. Nicotine Tob Res 1:11-20
5. Daynard RA (2004) Roles of tobacco litigation and societal change. In: Boyle P, Gray N, Henningfield JE, Seffrin J, Zatonski W (eds) Tobacco and public health: science and policy. Oxford Univ Press, Oxford, UK, pp 695-705
6. DeNoble VJ, Mele PC (2006) Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone. Psychopharmacology - PRESENT ISSUE
7. Drobes D, Klein LC (2004) Research on nicotine and tobacco: a decade of progress. Nicotine Tob Res 6:695-741
8. Ferno O (1973) A substitute for tobacco smoking. Psychopharmacologia 31:201-204
9. Ferno O (1977) The Development of a chewing gum containing nicotine and some comments on the role played by nicotine in the smoking habit. In: Steinfeld J, Griffiths W, Ball K, Taylor RM (eds) Proceedings of the 3rd world conference on smoking and health. Smoking & health. US Department of Health, Education, and Welfare, Washington, DC, pp 569-573
10. Finnegan JK, Larson PS, Haag HB (1945) The role of nicotine in the cigarette habit. Science 102:94-96
11. Food and Drug Administration (1995) Regulations restricting the sale and distribution of cigarettes and smokeless tobacco products to protect children and adolescents; proposed rule analysis regarding FDA's jurisdiction over nicotine-containing cigarettes and smokeless tobacco products; notice. Fed Regist 60:41314-41792
12. Food and Drug Administration (1996) Regulations restricting the sale and distribution of cigarettes and smokeless tobacco to protect children and adolescents; final rule. Fed Regist 61:44396-45318
13. Goldberg SR, Spealman RD, Goldberg DM (1981) Persistent behavior at high rate maintained by intravenous self-administration of nicotine. Science 214:573-575
14. Goldberg SR, Spealman RD, Risner ME, Henningfield JE (1983) Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behave 19:1011-1020
15. Griffiths RR, Henningfield JE (1982) Experimental analysis of human cigarette smoking behavior. Fed Proc 41:234-240
16. Gritz ER (1980) Smoking behavior and tobacco use. In: Mello NK (ed) Advances in substance abuse. JAI Press Inc., Greenwich, CT, pp 91-158
17. Grunberg NE, Popp KA, Bowen DJ, Nespor SM, Winders SE, Eury SE (1988) Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norepinephrine. Life Sci 42:161-170
18. Hall SM, Tunstall CD, Ginsberg D, Benowitz NL, Jones RT (1987) Nicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol 55:603-605
19. Harris LS (1988) Problems of drug dependence 1987, NIDA research monograph no. 81, proceedings of the 49th annual scientific meeting, the committee on problems of drug dependence, Inc. Public Health Service, Department of Health and Human Services, Rockville, MD
20. Hatsukami DK, Hughes JR, Pickens RW, Svikis D (1984) Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology 84:231-236
21. Hatsukami DK, Giovino GA, Eissenberg T, Clark PI, Lawrence D, Leischow S (2005) Methods to assess potential reduced exposure products. Nicotine Tob Res 7:827-844
22. Henningfield JE (1984) Behavioral Pharmacology of Cigarette Smoking. In: Thompson T, Dews PB, Barrett JE (eds) Advances in Behavioral Pharmacology, vol 4. Academic, New York, pp 131-210
23. Henningfield JE (1995) Statement of David Kessler, Commissioner of Food and Drugs, Food and Drug Administration, Accompanied by Jack E. Henningfield, Chief, Clinical Pharmacology Branch, National Institute on Drug Abuse. Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, Second Session. US Government Printing Office, Washington, DC, pp 36-37
24. Henningfield JE (2004) Written direct examination of Jack E. Henningfield, PhD. submitted by the United States pursuant to order #471; United States District Court for the District of Columbia, United States, Plaintiff, versus Philip Morris USA Inc., et al. Defendants. Available at: http://www.usdoj.gov/civil/ cases/tobacco2/Henningfield%20Written%20Direct.pdf
25. Henningfield JE, Goldberg SR (1983) Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav 19:989-992
26. Henningfield JE, Hartel CR (1999) Scientific basis for tobacco policy: nicotine research travails. In: Glantz MD, Hartel CR (eds) Drug Abuse: Origins and Interventions. American Psychological Association, Washington, DC, pp 431-446
27. Henningfield JE, Zeller M (2002) Could science-based regulation make tobacco products less addictive? Yale J Health Policy Law Ethics III:127-138
28. Henningfield JE, Miyasato K, Jasinski DR (1983) Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav 19:887-890
29. Henningfield JE, Miyasato K, Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12
30. Henningfield JE, London ED, Jaffe JH (1987) Nicotine Reward: Studies of Abuse Liability and Physical Dependence Potential. In: Engel J, Orleand L (eds) Brain Reward Systems and Abuse. Raven Press, New York, NY, pp 147-164
31. Henningfield JE, Keenan RM, Clarke PBS (1996) Nicotine. In: Schuster CR, Kuhar MJ (eds) Handbook of Experimental Pharmacology. Springer, Berlin Heidelberg New York, pp 214-271
32. Henningfield JE, Benowitz NL, Connolly GN, Davis RM, Gray N, Myers ML, Zeller M (2004) Reducing tobacco addiction through tobacco product regulation. Tob Control 13:132-135
33. Henningfield JE, Burns DM, Dybing E (2005a) Guidance for research and testing to reduce tobacco toxicant exposure. Nicotine Tob Res 7(6):821-826
34. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML (2005b) Pharmacotherapy of nicotine dependence. CA: A cancer journal for clinicians. CA Cancer J Clin 55:281-299
35. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294
36. Hurt RD, Robertson CR (1998) Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial. JAMA 280:1173-1181
37. Jaffe JH, Jarvik ME (1978) Tobacco Use and Tobacco Disorder. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: a Generation of Progress. Raven Press, New York, NY, pp 1665-1676
38. Jarvik ME (1977) Biological factors underlying the smoking habit. In: Jarvik ME, Cullen JW, Gritz ER, Vogt TM, West LJ (eds) Research on smoking behavior. NIDA research monograph 17. U.S. Department of Health, Education, and Welfare, Washington, DC, pp 122-148
39. Jarvik ME, Cullen, JW, Gritz ER, Vogt TM, West LJ (1977) Research on smoking behavior, NIDA Research Monograph 17. Department of Health, Education and Welfare. DHEW Publication No. (ADM), Washington, DC, pp 78-581
40. Johnston LM, Glasg MB (1941) Tobacco smoking and nicotine. Lancet 1:867
41. Kessler DA (1995) Statement of David Kessler, Commissioner of Food and Drugs, Food and Drug Administration, Accompanied by Jack E. Henningfield, Chief, Clinical Pharmacology Branch, National Institute on Drug Abuse. Hearings Before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, Second Session. U.S. Government Printing Office, Washington, DC, pp 28-43
42. Kessler DA (2001) A Question of Intent: a Great American Battle With a Deadly Industry. Public Affairs, New York, NY
43. Koop CE (2003) Tobacco addiction: accomplishments and challenges in science, health, and policy. Nicotine Tob Res 5:613-619
44. Koop EC (2004) Tobacco: the public health disaster of the twentieth century. In: Boyle P, Gray N, Henningfield JE, Seffrin J, Zatonski W (eds) Tobacco and public health: science and policy. Oxford Univ Press, Oxford, UK, pp v-xvii
45. Krasnegor NA (1979a) Cigarette smoking as a dependence process, NIDA research monograph no. 23. Public Health Service, Department of Health Education, and Welfare, Washington, DC
46. Krasnegor NA (1979b) The behavioral aspects of smoking, NIDA Research Monograph No. 26. US Government Printing Office, Washington, DC
47. Langley JN (1905) On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J Physiol (London) 33:374-413
48. Lewin L (1998) Phantastica: a classic survey on the use and abuse of mind-altering plants. Park Street, Rochester, VT
49. London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M (1988) Effects of nicotine on local cerebral glucose utilization in the rat. J Neurosci 8:3920-3928
50. Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC (1986) Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Mol Pharmacol 30:427-436
51. Myers ML (2002) Could product regulation result in less hazardous tobacco products? Yale J Health Policy Law Ethics III:139-147
52. National Cancer Institute (2001) Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine, smoking and tobacco control monograph 13. National Institutes of Health, National Cancer Institute, Bethesda, MD
53. National Institute on Drug Abuse (1984) Drug Abuse and Drug Abuse Research. Public Health Service, US Department of Health and Human Services, Rockville, MD
54. Overton DA (1969) Control of T-maze choice by nicotinic, antinicotinic, and antimuscarinic drugs. Proceedings of the 77th annual American psychological association convention, American Psychological Association, Washington DC
55. Perkins KA, DiMarco A, Grobe JE, Scierka A, Stiller RL (1994a) Nicotine discrimination in male and female smokers. Psychopharmacology 116:407-413
56. Perkins KA, Sexton JE, Reynolds WA, Grobe JE, Fonte C, Stiller RL (1994b) Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking versus nasal spray. Pharmacol Biochem Behav 47:295-299
57. Pinney JM (1979) Preface. In: Krasnegor NA (ed) Cigarette smoking as a dependence process. NIDA research monograph no. 23. Public Health Service, US Department of Health Education and Welfare, Washington, DC, pp vii-viii
58. Posselt W, Reimann L (1828) Chemische untersuchungen des tabaks und darstellung des eigenthumlichen wirksamen princips dieser pflanze. Geigers Magazin der Pharmazie 24:138-161
59. Pomerleau OF, Hughes JR (2005) With a little help from its friends: a brief history of the society for research on nicotine and tobacco. Available at: http://www.srnt.org/about/history/briefhist.htm
60. Rose JE, Jarvik ME, Rose KD (1984) Transdermal administration of nicotine. Drug Alcohol Depend 13:209-213
61. Rosecrans JA, Kallman MJ, Glennon R (1978) The Nicotine Cue: an Overview. In: Colpaert FC, Rosecrans JA (eds) Stimulus Properties of Drugs: Ten Years of Progress. Elsevier/North-Holland Biomedical Press, Amsterdam, NL, pp 69-81
62. Russell MAH (1971) Cigarette smoking: natural history of a dependence disorder. Br J Med Psychol 44:1-16
63. Russell MAH (1979) Tobacco Dependence: Is Nicotine Rewarding or Aversive? In: Krasnegor NA (ed) Cigarette Smoking As a Dependence Process. NIDA Research Monograph 23. Public Health Service, US Department of Health Education and Welfare, Washington, DC 100-122
64. Russell MAH (1988) Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. In: Pomerleau OF, Pomerleau CS, Fagerstrom KO, Henningfield JE, Hughes JR (eds) Nicotine replacement: a critical evaluation. Alan R. Liss, Inc., New York, NY 63-94
65. Russell MA (1991) The future of nicotine replacement. Br J Addict 86:653-658
66. Schneider NG, Jarvik ME, Forsythe AB (1984) Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9:149-156
67. Schwartz JL (1987) Review and Evaluation of Smoking Cessation Methods: the United States and Canada, 1979-1985. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 87-2940, Rockville, MD
68. Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214-216
69. Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50:35-39
70. Slade J, Bero LA, Hanauer P, Barnes DE, Glantz SA (1995) Nicotine and addiction. The Brown and Williamson documents. JAMA 274:225-233
71. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 28:247-259
72. US Department of Health Education and Welfare (1964) Smoking and health: report of the advisory committee to the surgeon general of the public health service. US Department of Health, Education and Welfare, Washington DC
73. US Department of Health and Human Services (1984) Why people smoke cigarettes. PHS 83-50195, pp1-5
74. US Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Center for Health Promotion and Education, Office on Smoking and Health, Rockville, MD
75. US Department of Health Education and Welfare (1979) Smoking and health, a report of the surgeon general. U.S. Government Printing Office, Washington, DC
76. Vagg R, Chapman S (2005) Nicotine analogues: a review of tobacco industry research interests. Addiction 100:701-712
77. World Health Organization (2001) Advancing Knowledge on Regulating Tobacco Products. World Health Organization, Geneva, Switzerland Available at: http://whqlibdoc.who.int/ hq/2001/WHO_NMH_TFI_01.2.pdf
78. World Health Organization (2005) WHO Framework Convention on Tobacco Control. Geneva, Switzerland: WHO Document Production Services (available at: http://www.who.int/tobacco/ framework/en/)
79. World Health Organization Study Group on Tobacco Product Regulation (2004) Recommendation: Guiding Principles for the Development of Tobacco Product Research and Testing Capacity and Proposed Protocols for the Initiation of Tobacco Product Testing. World Health Organization, Geneva, Switzerland